Matthew K. Szot - Chief Financial Officer at Cadrenal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CVKD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew K. Szot since 9/13/2023

Holdings reported by Matthew K. Szot for Cadrenal Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 500K $345K $0.69 Jan 24, 2023 Direct
Stock Options 250K Jan 18, 2024 Direct Common Stock

Transactions reported by Matthew K. Szot for Cadrenal Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.